{
    "Trade/Device Name(s)": [
        "cobas\u00ae CT/NG v2.0 Test",
        "cobas\u00ae CT/NG Test"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K140887",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132270",
        "K110923"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL",
        "MKZ",
        "OOI"
    ],
    "Summary Letter Date": "May 5, 2014",
    "Summary Letter Received Date": "April 7, 2014",
    "Submission Date": "April 4, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3390",
        "21 CFR 866.3120",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagent",
        "Chlamydia serological reagents",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis (CT) DNA",
        "Neisseria gonorrhoeae (NG) DNA",
        "CT cryptic plasmid DNA",
        "CT ompA gene",
        "NG genomic DNA"
    ],
    "Specimen Type(s)": [
        "Male urine",
        "Female urine",
        "Self-collected vaginal swab",
        "Clinician-collected vaginal swab",
        "Endocervical swab",
        "Cervical specimen"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae PCR Female Swab Sample Kit",
        "cobas\u00ae PCR Urine Sample Kit",
        "PreservCyt\u00ae vial"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 4800 System",
        "cobas x 480 instrument",
        "cobas z 480 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid amplification",
        "TaqMan technology",
        "Fluorescence resonance energy transfer (FRET)"
    ],
    "Methodologies": [
        "PCR amplification",
        "Automated nucleic acid extraction",
        "Qualitative detection",
        "Nucleic acid hybridization"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analysis Package",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Roche cobas CT/NG v2.0 and cobas CT/NG qualitative in vitro nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA using cobas 4800 system with updated software version 2.1.",
    "Indications for Use Summary": "Automated, qualitative nucleic acid amplification tests to aid in the diagnosis of chlamydial and gonococcal disease by detecting Chlamydia trachomatis and/or Neisseria gonorrhoeae DNA in urine, vaginal, endocervical, and cervical specimens, for use with specified cobas sample collection kits and the cobas 4800 system.",
    "fda_folder": "Microbiology"
}